Alpharma API Hong Kong And Zhejiang Hisun Establish Joint Venture To Expand API Production
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Alpharma API Hong Kong and Taizhou-based Zhejiang Hisun Pharmaceutical will establish a new joint venture facility to produce antibiotic Vancomycin and other APIs, Hisun announced on June 12